1. Home
  2. GRFS vs SBSW Comparison

GRFS vs SBSW Comparison

Compare GRFS & SBSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRFS
  • SBSW
  • Stock Information
  • Founded
  • GRFS 1940
  • SBSW 2013
  • Country
  • GRFS Spain
  • SBSW South Africa
  • Employees
  • GRFS N/A
  • SBSW N/A
  • Industry
  • GRFS Biotechnology: Pharmaceutical Preparations
  • SBSW Precious Metals
  • Sector
  • GRFS Health Care
  • SBSW Basic Materials
  • Exchange
  • GRFS Nasdaq
  • SBSW Nasdaq
  • Market Cap
  • GRFS 7.2B
  • SBSW 6.4B
  • IPO Year
  • GRFS 2006
  • SBSW N/A
  • Fundamental
  • Price
  • GRFS $9.87
  • SBSW $8.63
  • Analyst Decision
  • GRFS Hold
  • SBSW Hold
  • Analyst Count
  • GRFS 1
  • SBSW 3
  • Target Price
  • GRFS $10.30
  • SBSW $6.07
  • AVG Volume (30 Days)
  • GRFS 489.5K
  • SBSW 7.9M
  • Earning Date
  • GRFS 01-01-0001
  • SBSW 08-28-2025
  • Dividend Yield
  • GRFS 1.47%
  • SBSW N/A
  • EPS Growth
  • GRFS 132.60
  • SBSW N/A
  • EPS
  • GRFS 0.53
  • SBSW N/A
  • Revenue
  • GRFS $8,744,226,659.00
  • SBSW $6,290,132,787.00
  • Revenue This Year
  • GRFS $6.00
  • SBSW $7.63
  • Revenue Next Year
  • GRFS $6.71
  • SBSW $5.23
  • P/E Ratio
  • GRFS $24.37
  • SBSW N/A
  • Revenue Growth
  • GRFS 9.32
  • SBSW 3.11
  • 52 Week Low
  • GRFS $6.19
  • SBSW $3.05
  • 52 Week High
  • GRFS $11.14
  • SBSW $9.85
  • Technical
  • Relative Strength Index (RSI)
  • GRFS 47.26
  • SBSW 52.86
  • Support Level
  • GRFS $9.63
  • SBSW $8.44
  • Resistance Level
  • GRFS $10.14
  • SBSW $8.84
  • Average True Range (ATR)
  • GRFS 0.18
  • SBSW 0.29
  • MACD
  • GRFS -0.02
  • SBSW 0.06
  • Stochastic Oscillator
  • GRFS 46.15
  • SBSW 75.74

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About SBSW D/B/A Sibanye-Stillwater Limited ADS

Sibanye Stillwater Ltd is a South African mining and metals processing group with a diverse portfolio of operations, projects, and investments across five continents. The Group is also one of the foremost recyclers of PGM autocatalysts and has interests in mine tailings retreatment operations. It is a producer of platinum, palladium, and rhodium and is a top-tier gold producer. It also produces and refines iridium and ruthenium, nickel, chrome, copper, and cobalt. Its products are Gold, Nickel, Zinc, Chrome, PGMs, and other.

Share on Social Networks: